Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Exploratory Clinical Trial to Assess the Safety, Tolerability and Effectiveness of a Switching From Talipexole to Pramipexole

NCT02231905 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02231905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02231905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Exploratory Clinical Trial to Assess the Safety, Tolerability and Effectiveness of a Switching From Talipexole to Pramipexole
Lead sponsor
Boehringer Ingelheim
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
Not reported
Enrollment
29 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease